The clinical signs of CLN2 disease include speech delay, gross motor delay, seizures and ataxia typically evident from 2 to 4 years of age, followed by rapid neurocognitive decline, deterioration in motor and visual abilities, and early death in the first decade of life7–10. This evidence concerns the gene TPP1 and cerebellar ataxia.